La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic
- 1 September 2010
- journal article
- Published by Elsevier BV in Virology
- Vol. 404 (2), 139-147
- https://doi.org/10.1016/j.virol.2010.04.012
Abstract
No abstract availableKeywords
Funding Information
- PHS (1R01AI074626-01 and DFG 2616/2-3)
This publication has 27 references indexed in Scilit:
- Activation of cyclin‐dependent kinase 5 by calpains contributes to human immunodeficiency virus‐induced neurotoxicityJournal of Neurochemistry, 2007
- Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066–1087) as the fusion peptideVirology, 2007
- Human Immunodeficiency Virus (HIV)-Induced Neurotoxicity: Roles for the NMDA Receptor SubtypesJournal of Neuroscience, 2006
- Efficient cDNA-Based Rescue of La Crosse Bunyaviruses Expressing or Lacking the Nonstructural Protein NSsJournal of Virology, 2005
- Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsidsJournal of General Virology, 2003
- Serum‐free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrusJournal of Neuroscience Research, 1995
- Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSmJournal of General Virology, 1994
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- The Large Viral RNA Segment of California Serogroup Bunyaviruses Encodes the Large Viral ProteinJournal of General Virology, 1989
- Organization of the middle RNA segment of snowshoe hare bunyavirusVirology, 1988